178 related articles for article (PubMed ID: 30935663)
21. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
[TBL] [Abstract][Full Text] [Related]
22. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
[TBL] [Abstract][Full Text] [Related]
23. Impact of ovarian endometrioma on oocytes and pregnancy outcome in in vitro fertilization.
Suzuki T; Izumi S; Matsubayashi H; Awaji H; Yoshikata K; Makino T
Fertil Steril; 2005 Apr; 83(4):908-13. PubMed ID: 15820799
[TBL] [Abstract][Full Text] [Related]
24. Pregnancy outcome in women with endometriosis achieving pregnancy with IVF.
Benaglia L; Candotti G; Papaleo E; Pagliardini L; Leonardi M; Reschini M; Quaranta L; Munaretto M; Viganò P; Candiani M; Vercellini P; Somigliana E
Hum Reprod; 2016 Dec; 31(12):2730-2736. PubMed ID: 27664955
[TBL] [Abstract][Full Text] [Related]
25. Ovarian stimulation for in vitro fertilization in patients with endometriosis.
Zikopoulos K; Kolibianakis EM; Devroey P
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):651-5. PubMed ID: 15225190
[TBL] [Abstract][Full Text] [Related]
26. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
27. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
28. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
29. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
30. Endometriosis and IVF: are agonists really better? Analysis of 1180 cycles with the propensity score matching.
Rodriguez-Purata J; Coroleu B; Tur R; Carrasco B; Rodriguez I; Barri PN
Gynecol Endocrinol; 2013 Sep; 29(9):859-62. PubMed ID: 23875964
[TBL] [Abstract][Full Text] [Related]
31. Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI.
Mijatovic V; Florijn E; Halim N; Schats R; Hompes P
Eur J Obstet Gynecol Reprod Biol; 2010 Jul; 151(1):62-5. PubMed ID: 20409633
[TBL] [Abstract][Full Text] [Related]
32. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
33. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
34. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
35. Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study.
D'Amato G; Caringella AM; Stanziano A; Cantatore C; Palini S; Caroppo E
Reprod Biol Endocrinol; 2018 Sep; 16(1):89. PubMed ID: 30217209
[TBL] [Abstract][Full Text] [Related]
36. The comparision of effect of microdose GnRH-a flare-up, GnRH antagonist/aromatase inhibitor letrozole and GnRH antagonist/clomiphene citrate protocols on IVF outcomes in poor responder patients.
Ozcan Cenksoy P; Ficicioglu C; Kizilkale O; Suhha Bostanci M; Bakacak M; Yesiladali M; Kaspar C
Gynecol Endocrinol; 2014 Jul; 30(7):485-9. PubMed ID: 24592985
[TBL] [Abstract][Full Text] [Related]
37. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting clinical outcomes after IVF-ET for infertile young patients with ovarian endometrioma: A 5-year retrospective cohort study.
Zhou F; Zhao F; Jin X; Li C; Zhang S
Medicine (Baltimore); 2022 Jul; 101(26):e29793. PubMed ID: 35777051
[TBL] [Abstract][Full Text] [Related]
39. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone.
Guo YH; Lu N; Zhang Y; Su YC; Wang Y; Zhang YL; Sun YP
Contemp Clin Trials; 2012 Nov; 33(6):1206-10. PubMed ID: 22820320
[TBL] [Abstract][Full Text] [Related]
40. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis.
Surrey ES; Silverberg KM; Surrey MW; Schoolcraft WB
Fertil Steril; 2002 Oct; 78(4):699-704. PubMed ID: 12372443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
